If you dismiss “quality culture” as mere industry jargon, prepare to struggle. We’ve come a long way since the FDA’s 2014 quality metrics initiative led to a greater focus on quality culture. It’s no longer a nice-to-have; it’s an imperative.

Ingraining a robust quality culture brings efficiency, reliability and sustainable compliance to life science businesses just like yours. It means greater opportunities for success and fewer manufacturing problems in the long run.

And with both on-site and remote FDA inspections set to rise in 2022 thanks to a budget increase from Congress, now is the time to create a quality culture in your company. Or risk losing market share and competitive advantages … permanently.

While the original strategies primarily emphasized executive management’s role, best practices now dictate other tactics.

In this webinar, Susan Schniepp, distinguished fellow at Regulatory Compliance Associates®, will explain these approaches in how to build quality culture within your organization.

She will share why quality culture is a must; new quality culture tools and standards under development by the Parenteral Drug Association (PDA) and other organizations; and best practices, including case studies with lessons learned.

Webinar Takeaways:

• Define the leadership objectives that must be at the root of quality initiatives
• Achieve buy-in so that employees accept and adhere to product integrity and ethical standards
• Encourage an open discussion of quality hazards at each stage of business
• Promote — and gain wide acceptance for — collaboration, and how to assess your team gaps
• Why commitment to professional development and quality training is critical to success

 

Until every single member of your team — and your organization — buys into increasing overall quality, you will fall behind. This webinar will enable you to build a quality culture that works.